Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

47.94 -0.09 (-0.19%)
Streaming Delayed Price Updated: 9:45 AM EST, Dec 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
January 17, 2006
Form 8-K
Source: SEC/Edgar
January 11, 2006
Form 8-K/A
Source: SEC/Edgar
January 10, 2006
Form 8-K
Source: SEC/Edgar
January 05, 2006
Form 8-K
Source: SEC/Edgar
January 03, 2006
Form 425
Source: SEC/Edgar
December 26, 2005
Form 8-K
Source: SEC/Edgar
December 26, 2005
Form 8-K
Source: SEC/Edgar
December 26, 2005
Form 8-K
Source: SEC/Edgar
December 22, 2005
Form 8-K
Source: SEC/Edgar
December 20, 2005
Form 8-K
Source: SEC/Edgar
December 15, 2005
Form 8-K
Source: SEC/Edgar
December 13, 2005
Form 424B5
Source: SEC/Edgar
December 13, 2005
Form 424B5
Source: SEC/Edgar
December 12, 2005
Form 8-K
Source: SEC/Edgar
December 12, 2005
Form 8-K
Source: SEC/Edgar
December 08, 2005
Form 8-K
Source: SEC/Edgar
December 04, 2005
Form 8-K
Source: SEC/Edgar
November 28, 2005
Form 8-K
Source: SEC/Edgar
November 15, 2005
Form 8-K
Source: SEC/Edgar
November 15, 2005
Form 10QSB
Source: SEC/Edgar
November 13, 2005
Form 10QSB
Source: SEC/Edgar
November 13, 2005
Form 8-K
Source: SEC/Edgar
October 31, 2005
Form 8-K
Source: SEC/Edgar
October 26, 2005
Form 8-K
Source: SEC/Edgar
October 26, 2005
Form 8-K
Source: SEC/Edgar
October 26, 2005
Form 424B3
Source: SEC/Edgar
October 17, 2005
Form DEF 14A
Source: SEC/Edgar
October 06, 2005
Form 10KSB
Source: SEC/Edgar
September 27, 2005
Form 8-K
Source: SEC/Edgar
September 25, 2005
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.